RAC 2.30% $1.49 race oncology ltd

Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-100

  1. 2,987 Posts.
    lightbulb Created with Sketch. 3625
    Yes, obviously holders were more than happy to see it happen...

    Stick around, you might learn a thing or two about removing dead weight from the board that are misaligned with shareholders
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.